FDA clears Siemens' SieScape technique
Siemens Ultrasound Group in Issaquah, WA, will use momentum generatedwith the 1995 launch of the 256-channel Sonoline Elegra as a springboardto this year's show. Heading the division's new product offeringswill be SieScape, an image-processing technique
Siemens Ultrasound Group in Issaquah, WA, will use momentum generatedwith the 1995 launch of the 256-channel Sonoline Elegra as a springboardto this year's show. Heading the division's new product offeringswill be SieScape, an image-processing technique that allows real-timeimaging of extremely large fields-of-view (SCAN 12/13/95).
With SieScape, a technologist can capture continuous acquisitionscovering nearly unlimited sweeps across the patient's body. Thedisplay pans across the acquisition at standard frame rates andmay be frozen over specific areas of interest. SieScape received510(k) clearance in October.
Also look for Siemens to discuss its Managed Healthcare Servicesdivision, which was formed earlier this year to offer businessconsulting services to radiology departments and hospitals (SCAN5/8/96).
In nuclear medicine, the variable-angle dual-head E.Cam willreprise the starring role it held at the Society of Nuclear Medicinemeeting in June (SCAN 6/5/96). Siemens will emphasize high-energytechniques for the system and plans to begin commercial shipmentsin November.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
